C3 President Speaks at NIH Meeting on Expansion of ClinicalTrials.Gov

Posted by Kate Murphy on April 20th, 2009
Carlea Bauman

Carlea Bauman

Carlea Bauman, President of C3: Colorectal Cancer Coalition spoke today. April 20, 2009, at a public meeting called by the National Institutes of Health to hear input on expansion of its clinical trials registry.

In calling for the ClinicalTrials.Gov database to include results of all clinical trials, Bauman said,

C3:Colorectal Cancer Coalition is committed to providing results of clinical trials that affect patients with colon and rectal cancer fairly and honestly, providing both positive and negative conclusions, and helping patients to understand what the results mean to them in language they can understand.

Read the rest of this entry »

Tags: , Comments (1): Add a comment

Running to Raise Lynch Syndrome Awareness

Posted by Kate Murphy on April 20th, 2009

selena-runSelena Martinez ran the Santa Cruz Half Marathon on April 19th to raise awareness of Lynch syndrome, or hereditary non-polyposis colon cancer (HNPCC), a genetic condition that greatly increases risk for colorectal and other cancers.

The Santa Cruz was the third of eight half marathons, Martinez plans to run to honor of eight members of her family diagnosed with Lynch syndrome cancers.  Sunday’s race was for her sister Noemi Garza who survived colon and endometrial cancer.

Martinez’ website Detect the Mutation provides information about recognizing and testing for Lynch syndrome. She is also raising funds for the University of California at San Francisco’s Gastrointestinal Cancer Prevention Program, which offers screenings to those in need. Read the rest of this entry »

Colorectal Cancer News in Brief: April 17

Posted by Kate Murphy on April 17th, 2009

This week we have research reports about risk of complications after hand-assisted laparoscopic colectomies, the benefit of music therapy during hospice treatment, and a gene that predicts better response to cetuximab.

In other headlines, we found an excellent overview of the progress made in colorectal cancer treatment with data and references.  In addition, there is information about management of colonoscopy sedation in HIV patients receiving antiretroviral medicines and a lifting of the FDA ban on concentrated liquid morphine for terminally ill patients until an acceptable substitute can be found. Read the rest of this entry »

FDA: Influend Cough and Cold Products Recalled

Posted by Kate Murphy on April 17th, 2009

Ion Labs, Inc. of Clearwater Florida is voluntarily recalling all Influend cough and cold products, both tablets and liquids, sold on or after May 30, 2008.  Because of testing issues, the products may contain more active ingredients and have the potential to be extra potent.

While the lots in question were sold in Huntsville, Alabama, Ion is recalling all Influend products to be safe. Read the rest of this entry »

Tags: , , , Comments (0): Add a comment

Crack a Smile for Colorectal Cancer

Posted by Kate Murphy on April 16th, 2009

crack-a-smile-iconOn April 18th, the fifth annual Crack A Smile Comedy Show will benefit the Colorectal Cancer Association of Canada (CCAC).

  • Crack A Smile Comedy Show
  • Saturday, April 18, 2009 starting at 8:15 p.m.
  • Toronto Centre for the Arts
  • George Weston Recital Hall
  • 5040 Yonge St, (north of Sheppard Ave)
  • Toronto, ON

Read the rest of this entry »

Page 3 of 712345...Last »